Angebote zu "Adenocarcinoma" (6 Treffer)

Kategorien

Shops

Bcl-2 expression in prostatic adenocarcinoma
49,00 € *
ggf. zzgl. Versand

Bcl-2 expression in prostatic adenocarcinoma ab 49 € als Taschenbuch: A study of histopathological features and Bcl-2 expression in prostatic adenocarcinoma - pre and post androgen ablation. Aus dem Bereich: Bücher, Wissenschaft, Medizin,

Anbieter: hugendubel
Stand: 20.02.2020
Zum Angebot
Methods of Cancer Diagnosis, Therapy and Prognosis
162,99 € *
ggf. zzgl. Versand

This third volume in the series Methods of Cancer Diagnosis, Therapy and Prognosis discusses diagnosis, therapy, and prognosis of Gastrointestinal Cancers. Both standard and emerging therapies for these cancers, written by expert oncologists/pathologists in this field, are included.This fully illustrated volume* Includes various aspects of esophageal cancer, gastric cancer, and pancreatic cancer* Highlights the methodologies used for diagnosis, therapy, and prognosis of these different cancers* Explains the molecular mechanisms underlying these cancers* Discusses the evaluation of FDG-PET/CT fusion imaging, endoscopic ultrasound and imaging, and the role of microRNA in prognosis* Details the classification of colon and gastric histological samples* Highlights treatments, including radiofrequency ablation and surgical debulking, endoscopic submucosal dissection, laparoscopic gastrectomy of gastric cancer and pancreaticoduodenectomy* Reviews use of radiotherapy and chemotherapy for pancreatic cancer patients* Discusses a large number of imaging modalities for diagnosing these cancers and assessing the different treatmentsProfessor Hayat has summarized the problems associated with the complexities of research publications and has been successful in editing a must-read volume for oncologists, cancer researchers, medical teachers and students of cancer biology.Each year, tens of millions of people are respectively. The following data indicate diagnosed worldwide with cancer, and the burden (seriousness) of gastrointestinal more than half of these patients eventu- cancer, liver cancer, and colorectal cancers ally die from this disease. The severity of globally and in the United States. (Table 1) the burden of cancer becomes really clear Surgical and molecular therapies and pr- by knowing that there were ? 10, 862, 496 nostic markers for gastrointestinal stromal new cancer cases (excluding skin cancer) tumors are discussed in this volume. Role in the world in 2002, and the number of of anticancer drugs and monoclonal an- deaths caused by this disease in the same bodies specific for these tumors are also year was ? 6,723,887 (GLOBOCAN). discussed. Imaging modality assessing the The number of deaths due to cancer in the effect of anticancer imatinib on these tumors United States was estimated to be 559, 650 is included. Diagnostic and prognostic (Am. Cancer Soc. ). Cancer is caused by markers of clinical outcomes using che- both external factors (tobacco, chemicals, therapy and hormone replacement therapy radiation, and infectious organisms) and for gastric adenocarcinoma are detailed. internal factors (inherited mutations, hor- Also, are discussed immunohistochem- mones, immune conditions, and mutations try of esophageal cancer progression, and that occur from metabolism). diagnostic and therapeutic methodologies All cancer types caused by cigarette for biliary tumors.

Anbieter: buecher
Stand: 20.02.2020
Zum Angebot
Methods of Cancer Diagnosis, Therapy and Prognosis
162,99 € *
ggf. zzgl. Versand

This third volume in the series Methods of Cancer Diagnosis, Therapy and Prognosis discusses diagnosis, therapy, and prognosis of Gastrointestinal Cancers. Both standard and emerging therapies for these cancers, written by expert oncologists/pathologists in this field, are included.This fully illustrated volume* Includes various aspects of esophageal cancer, gastric cancer, and pancreatic cancer* Highlights the methodologies used for diagnosis, therapy, and prognosis of these different cancers* Explains the molecular mechanisms underlying these cancers* Discusses the evaluation of FDG-PET/CT fusion imaging, endoscopic ultrasound and imaging, and the role of microRNA in prognosis* Details the classification of colon and gastric histological samples* Highlights treatments, including radiofrequency ablation and surgical debulking, endoscopic submucosal dissection, laparoscopic gastrectomy of gastric cancer and pancreaticoduodenectomy* Reviews use of radiotherapy and chemotherapy for pancreatic cancer patients* Discusses a large number of imaging modalities for diagnosing these cancers and assessing the different treatmentsProfessor Hayat has summarized the problems associated with the complexities of research publications and has been successful in editing a must-read volume for oncologists, cancer researchers, medical teachers and students of cancer biology.Each year, tens of millions of people are respectively. The following data indicate diagnosed worldwide with cancer, and the burden (seriousness) of gastrointestinal more than half of these patients eventu- cancer, liver cancer, and colorectal cancers ally die from this disease. The severity of globally and in the United States. (Table 1) the burden of cancer becomes really clear Surgical and molecular therapies and pr- by knowing that there were ? 10, 862, 496 nostic markers for gastrointestinal stromal new cancer cases (excluding skin cancer) tumors are discussed in this volume. Role in the world in 2002, and the number of of anticancer drugs and monoclonal an- deaths caused by this disease in the same bodies specific for these tumors are also year was ? 6,723,887 (GLOBOCAN). discussed. Imaging modality assessing the The number of deaths due to cancer in the effect of anticancer imatinib on these tumors United States was estimated to be 559, 650 is included. Diagnostic and prognostic (Am. Cancer Soc. ). Cancer is caused by markers of clinical outcomes using che- both external factors (tobacco, chemicals, therapy and hormone replacement therapy radiation, and infectious organisms) and for gastric adenocarcinoma are detailed. internal factors (inherited mutations, hor- Also, are discussed immunohistochem- mones, immune conditions, and mutations try of esophageal cancer progression, and that occur from metabolism). diagnostic and therapeutic methodologies All cancer types caused by cigarette for biliary tumors.

Anbieter: buecher
Stand: 20.02.2020
Zum Angebot
Bcl-2 expression in prostatic adenocarcinoma
49,00 € *
ggf. zzgl. Versand

Bcl-2 expression in prostatic adenocarcinoma ab 49 EURO A study of histopathological features and Bcl-2 expression in prostatic adenocarcinoma - pre and post androgen ablation

Anbieter: ebook.de
Stand: 20.02.2020
Zum Angebot
PDT versus APC in Barrett's Esophagus
54,90 € *
ggf. zzgl. Versand

The aim of endoscopic ablation in the lower third of the esophagus is to eliminate the intestinal metaplasia and hence the risk of developing adenocarcinoma. Different methods have been advocated but, to date, none of them has been shown to be the standard. We used different methods according to individualized selection criteria. We support the use of PDT for patients with grade-4 IPN. Supplementary methods for the rest of Barrett are of particular value. EMR is suitable for elevated lesion with suspicion of IPN, as it provides considerable material for exact histopathological examination. APC is needed for the elimination of the residual islands of Barrett's epithelium. APC alone could be enough for grade-3 IPN within Barrett's muosa less than 5 cm in length, as it showed esophageal stricture when used for longer lesions. Endoscopic ablation therapy is highly effective in eradicating intraepithelial neoplasia (IPN) within Barrett's esophagus. The success in totally eradicating the metaplastic epithelium was much lower. Long-term follow-up is inevitable to prove the effectiveness of ablation therapy in reducing the incidence of adenocarcinoma of the esophagus.

Anbieter: Dodax
Stand: 20.02.2020
Zum Angebot